Centessa Pharmaceuticals plc SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13G/ACentessa Pharmaceuticals plcCNTAAug 14

   Ownership stake disclosure by Pentwater Capital Management LP (amended)

   Pentwater Capital Management LP, filed by

2. ROUTINESCHEDULE 13G/ACentessa Pharmaceuticals plcCNTAAug 14

   Ownership stake disclosure by INDEX VENTURES LIFE VI (JERSEY) L.P. (amended)

   INDEX VENTURES LIFE VI (JERSEY) L.P., filed by

3. ROUTINESCHEDULE 13G/ACentessa Pharmaceuticals plcCNTAAug 12

   Ownership stake disclosure by Adage Capital Management, L.P. (amended)

   Adage Capital Management, L.P., filed by

4. ROUTINESCHEDULE 13G/ACentessa Pharmaceuticals plcCNTAAug 4

   Ownership stake disclosure by Medicxi Growth I LP (amended)

   Medicxi Growth I LP, filed by

5. ROUTINESCHEDULE 13G/ACentessa Pharmaceuticals plcCNTAJul 8

   Ownership stake disclosure by FMR LLC (amended)

   FMR LLC, filed by

6. ROUTINE15-12GCentessa Pharmaceuticals plcCNTAJul 6

   Deregistration notice

7. NOTABLESCHEDULE 13D/ACentessa Pharmaceuticals plcCNTAJun 26

   Ownership stake disclosure by FARALLON CAPITAL MANAGEMENT, L.L.C. (amended)

   FARALLON CAPITAL MANAGEMENT, L.L.C., filed by

8. NOTABLESCHEDULE 13DCentessa Pharmaceuticals plcCNTAJun 24

   Ownership stake disclosure by FARALLON CAPITAL MANAGEMENT, L.L.C.

   FARALLON CAPITAL MANAGEMENT, L.L.C., filed by

9. ROUTINE4Centessa Pharmaceuticals plcCNTAJun 24

   17 insider filings

   Medicxi Growth I LP, insider filing for CNTA

   Show all 17

   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24
   • 4Insider filing for CNTAJun 24

   Medicxi Growth I LP, reporting · Medicxi Growth Co-Invest I LP, reporting · +8 more

10. ROUTINES-8 POSCentessa Pharmaceuticals plcCNTAJun 24

    S-8 POS filing

11. ROUTINES-8 POSCentessa Pharmaceuticals plcCNTAJun 24

    S-8 POS filing

12. ROUTINES-8 POSCentessa Pharmaceuticals plcCNTAJun 24

    S-8 POS filing

13. ROUTINES-8 POSCentessa Pharmaceuticals plcCNTAJun 24

    S-8 POS filing

14. ROUTINES-8 POSCentessa Pharmaceuticals plcCNTAJun 24

    S-8 POS filing

15. ROUTINES-8 POSCentessa Pharmaceuticals plcCNTAJun 24

    S-8 POS filing

16. ROUTINEPOSASRCentessa Pharmaceuticals plcCNTAJun 24

    POSASR filing

17. NOTABLE25-NSECentessa Pharmaceuticals plcCNTAJun 24

    Delisting notice

    Nasdaq Stock Market LLC, filed by

18. ROUTINE8-KCentessa Pharmaceuticals plcCNTAJun 24

    Current report

19. ROUTINE8-KCentessa Pharmaceuticals plcCNTAJun 12

    Current report

20. ROUTINE8-KCentessa Pharmaceuticals plcCNTAMay 22

    Current report

21. ROUTINE4Centessa Pharmaceuticals plcCNTAMay 18

    Mario Alberto Accardi, insider filing for CNTA

    Mario Alberto Accardi, reporting

22. ROUTINESCHEDULE 13GCentessa Pharmaceuticals plcCNTAMay 15

    Ownership stake disclosure by Pentwater Capital Management LP

    Pentwater Capital Management LP, filed by

23. ROUTINESCHEDULE 13G/ACentessa Pharmaceuticals plcCNTAMay 15

    Ownership stake disclosure by Avoro Capital Advisors LLC (amended)

    Avoro Capital Advisors LLC, filed by

24. ROUTINESCHEDULE 13G/ACentessa Pharmaceuticals plcCNTAMay 13

    Ownership stake disclosure by Adage Capital Management, L.P. (amended)

    Adage Capital Management, L.P., filed by

25. NOTABLEDEFM14ACentessa Pharmaceuticals plcCNTAMay 7

    Merger proxy statement

26. ROUTINESCHEDULE 13G/ACentessa Pharmaceuticals plcCNTAMay 6

    Ownership stake disclosure by FMR LLC (amended)

    FMR LLC, filed by

27. NOTABLE10-QCentessa Pharmaceuticals plcCNTAMay 5

    Quarterly report

28. ROUTINEARSCentessa Pharmaceuticals plcCNTAApr 29

    Annual report to shareholders

29. ROUTINEDEF 14ACentessa Pharmaceuticals plcCNTAApr 29

    Proxy statement

30. NOTABLEPREM14ACentessa Pharmaceuticals plcCNTAApr 17

    PREM14A filing

31. ROUTINEDEFA14ACentessa Pharmaceuticals plcCNTAApr 13

    Additional proxy materials

32. ROUTINEDEFA14ACentessa Pharmaceuticals plcCNTAMar 31

    Additional proxy materials

33. ROUTINEDEFA14ACentessa Pharmaceuticals plcCNTAMar 31

    Additional proxy materials

34. ROUTINEDEFA14ACentessa Pharmaceuticals plcCNTAMar 31

    Additional proxy materials

Older filings on EDGAR